HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 143 filers reported holding HEALTH CATALYST INC in Q3 2020. The put-call ratio across all filers is 0.39 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,058,679 | +9.8% | 90,718 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $964,332 | +26.9% | 90,718 | +15.8% | 0.02% | +20.0% |
| Q3 2022 | $760,000 | -33.0% | 78,308 | 0.0% | 0.02% | -28.6% |
| Q2 2022 | $1,135,000 | -28.2% | 78,308 | +29.4% | 0.02% | -12.5% |
| Q1 2022 | $1,581,000 | -87.2% | 60,500 | -80.5% | 0.02% | -85.0% |
| Q4 2021 | $12,321,000 | -22.0% | 310,979 | -1.6% | 0.16% | -26.9% |
| Q3 2021 | $15,805,000 | -10.6% | 316,044 | -0.7% | 0.22% | -14.1% |
| Q2 2021 | $17,673,000 | +28.4% | 318,379 | +8.2% | 0.26% | +23.2% |
| Q1 2021 | $13,762,000 | +8.5% | 294,244 | +1.0% | 0.21% | +2.5% |
| Q4 2020 | $12,685,000 | +24.8% | 291,404 | +5.0% | 0.20% | -1.5% |
| Q3 2020 | $10,162,000 | +40.1% | 277,644 | +11.7% | 0.20% | +29.7% |
| Q2 2020 | $7,251,000 | +27.6% | 248,567 | +14.4% | 0.16% | -4.8% |
| Q1 2020 | $5,683,000 | +39.8% | 217,342 | +85.5% | 0.17% | +69.4% |
| Q4 2019 | $4,065,000 | +25.1% | 117,137 | +14.1% | 0.10% | +18.1% |
| Q3 2019 | $3,249,000 | – | 102,690 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 1,574,175 | $15,930,651 | 10.16% |
| First Light Asset Management, LLC | 2,930,144 | $29,653,057 | 2.82% |
| Nepsis Inc. | 905,804 | $9,166,736 | 2.81% |
| Granahan Investment Management | 1,177,903 | $11,920,378 | 0.42% |
| Rhenman & Partners Asset Management AB | 320,000 | $3,238,400 | 0.35% |
| Bares Capital Management | 700,000 | $7,084,000 | 0.30% |
| PIER 88 INVESTMENT PARTNERS LLC | 101,470 | $1,026,876 | 0.26% |
| Counterpoint Mutual Funds LLC | 24,086 | $243,750 | 0.20% |
| Brendel Financial Advisors LLC | 11,831 | $120 | 0.18% |
| CVS HEALTH Corp | 32,273 | $326,598 | 0.18% |